HUNTINGTON BEACH, Calif., Oct. 6 /PRNewswire/ -- WayPoint Biomedical, Inc., a subsidiary of WayPoint Biomedical Holdings, Inc. (Pink Sheets: WYPH) is proud to announce that it has selected national convenience store broker TNT Marketing, Inc. to represent its products nationwide. In conjunction with TNT Marketing, WayPoint will co-exhibit at the upcoming NACS Tradeshow in Las Vegas (Oct. 9 - 11) where they will showcase their new Health Essist(R) Hangover-Free Patch(TM) at the TNT Booth (#2148). The company's Health Essist(R) Hangover-Free Patch(TM) will be the first of several unique new products to be marketed through TNT. Clinical studies show the simple and easy-to-use transdermal patch helps prevent hangover symptoms safely and effectively. The product also boasts drug-free, nutritionally beneficial natural ingredients, including vitamins, herbs and minerals. A patch may be proactively applied to the skin before consuming alcohol, and remains effective for up to 24 hours. The Health Essist(R) Hangover-Free Patch(TM) products promise strong C-store sales. With both clip-strip and counter-top display packaging, the three-patch packs are priced for quick turns. "TNT Marketing is excited to partner with WayPoint Biomedical," says Kennith Fries, TNT Marketing President. "The Health Essist(R) concept is going to rock sales in the convenience store class of trade." WayPoint Biomedical's Global Director of Sales and Marketing, Phill Richer, shares Fries' enthusiasm. "We are delighted to be working with TNT as we move our ground-breaking new product into C-stores," says Richer. "We anticipate a long partnership and impressive sales." About TNT Marketing, Inc.: TNT Marketing is an independent, national convenience store broker based in Arlington, Texas. The company's C-store experts, the C-storologists(SM), are industry specialists much like cardiologists, archaeologists and meteorologists. Focusing on the individual needs of wholesalers and retailers, the C-storologists(SM) offer individualized, efficient service, while building successful relationships. The C-storologists(SM) identify items that sell in C-stores, offer selling strategies to boost the bottom line and provide access to dozens of top brands including General Mills, Gillette, ConAgra, Bayer, Don Miguel, Mattel, Dole, Trojan, Duracell and Playtex in categories such as automotive, confection, toys, HBC, healthy alternatives, grocery, foodservice, frozen foods and snacks. About WayPoint Biomedical: WayPoint Biomedical, Inc., a wholly owned subsidiary of WayPoint Biomedical Holdings, Inc. (Pink Sheets: WYPH), is a pioneering new biomedical technology firm, specializing in diagnostic tests and devices for screening and monitoring human health, wellness, fitness and environment. The Company develops and markets a unique array of cutting-edge products, which includes their Health Essist(R) Hangover-Free Topical Patch for the Convenience Store market and their OTC approved Health Essist Drugs-of-Abuse product range. WayPoint's tests offer both a preliminary diagnostic screen to specific conditions, along with a future path for consumers, medical providers, and first responders to follow regarding their health status or environmental condition. WayPoint's unique and affordable home-based and on-site tests are focused on detecting the cause of a disease or pathogen, as opposed to determining the symptom; becoming a part of the solution to help reverse the escalating cost of Healthcare. The Company's primary target sectors are the Over the Counter (OTC) Wellness & Self-Testing Market, the Diagnostic Point of Care (POC) Testing Market, and the Homeland Security & Defense Market; three of the fastest growing areas in all of diagnostic medicine and science. For more information on WayPoint Biomedical and their product range visit http://www.waypointbiomedical.com/ , http://www.healthessist.com/ , http://www.drinkdetectiveusa.com/ . Included in this release are certain "forward-looking' statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding WayPoint's performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those referred to or implied by such statements. In addition, actual future results may differ materially from those anticipated, depending on a variety of factors, including continued maintenance of favorable license arrangements, success of market research identifying new product opportunities, successful introduction of new products, continued product innovation, the success of enhancements to WayPoint's brand image, sales and earnings growth, ability to attract and retain key personnel, and general economic conditions affecting consumer spending, including uncertainties relating to global political conditions, such as terrorism. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. WayPoint Biomedical does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law. Dennis Shepherd, 714-848-3200 E-mail: Investor Relations: The Steven Fox Group Steven Fox, 831-333-1452 E-mail: DATASOURCE: WayPoint Biomedical, Inc. CONTACT: Dennis Shepherd of WayPoint Biomedical Holdings, Inc., +1-714-848-3200, ; or Investor Relations, Steven Fox of The Steven Fox Group, +1-831-333-1452, , for WayPoint Biomedical Holdings, Inc. Web site: http://www.healthessist.com/ Web site: http://www.drinkdetectiveusa.com/ Web site: http://www.waypointbiomedical.com/

Copyright